N@N

Ekson Farma, Istanbul, Turkey, Reports Activar(R) AC-11(R) Next Generation Anti-Aging Skin Care and Oral Supplement Products Gr

^{Published on 2010-06-28 07:40:17 - Market Wire}
 

NEW YORK, NY--(Marketwire - June 28, 2010) - Optigenex Inc. (PINKSHEETS: [ OPGX ]) announced today its partner in Turkey, Ekson Farma, reports sales of its family of skin care products and oral supplements under the brand name, Activar® with AC-11®, is gaining support among a variety of health conscious and educated consumers in Turkey. Ekson, an exclusive licensee since early 2008, devoted nearly 2 years of market development and research before entering the mass market spring 2010.

All-natural and standardized at 8% Carboxy Alkyl Esters (CAE's™), AC-11® is the only patented aqueous extract of the Uncaria species that can make the following therapeutic claims ("DNA repair, Immune enhancement and Inhibition of pro-inflammatory agents") which are validated by a broad spectrum of scientific and clinical studies.

Daniel Zwiren, president and CEO of Optigenex Inc., said, "Ekson Farma, led by Doctor Yaman Er, have demonstrated perseverance during a very long sales cycle to mass market commercialization of the Activar® with AC-11® products earlier this year. Ekson was an early adopter of our technology and a company that understood the importance of educating the consumer about the key differentiators and health benefits of our patented ingredient AC-11®. As the Turkish consumer becomes better acquainted with our superior products, we expect sales to grow accordingly in this key geographic region."

Doctor Yaman Er, president of Ekson Farma, added, "We project sales of at least 10,000 units of Activar® with AC-11® products this year totaling approximately $400,000 in wholesale revenue. We estimate by September 2010 we will place a new order for Activar® Skin Care Products. Moreover, in cooperation with our partner Optigenex Inc. we plan to expand the product line to include a variety of new skin care applications utilizing AC-11®."

About Ekson Farma Ekson Farma: Founded in 1994, Ekson Farma is an applied sciences and marketing company focused on providing wellness solutions and related technologies to physicians, pharmacies and the general medical community. Ekson's strategy is to select superior and innovative products validated by clinical and scientific studies, establish consumer and physician acceptance through test marketing and ultimately distribute those products with the goal of improving the quality of life for health conscious consumers and patients. Ekson through its collaboration with research partner OKSANTE LABORATORIES is noted for its development of diagnostic tools utilizing DNA sequencing and molecular diagnostics with an emphasis on early detection of disease and DNA mutations.

About Optigenex Inc.:

Optigenex Inc. is a formulator, distributor and provider of proprietary next generation skin care, supplements and bulk ingredient featuring AC-11® (Formerly known as C-MED-100®) a patented compound as it core product. AC-11® is the bioactive, water-soluble form of the medicinal herb Uncaria tomentosa. For more information about Optigenex please visit our website: [ www.optigenex.com ]

* The statements made in this press release have not been evaluated by the Food and Drug Administration. These products mentioned in this release are not intended to diagnose, treat, cure or prevent any disease.